how to lose belly fat on glp 1 woman injecting a GLP-1 weight loss medication into Stock Photo GLP-1 Weight Loss & Loose

Obes Surg 34(10):38883896 Kellett J et al (2025) The efficacy of glucagon-like peptide-1 (GLP-1) receptor agonists for insufficient weight loss or regain after metabolic/bariatric surgery: a systematic review and meta-analysis

Limitations of Clinical Trials (relevant for setting expectations): Highly selected participants (extensive exclusion criteria) Regular monitoring and support (monthly visits) Free medication (eliminates cost/access barriers) Intensive lifestyle interventions (may exceed real-world adherence) Short duration (68-72 weeks) relative to chronic disease treatment needs Real-World Studies Findings : According to real-world evidence published in peer-reviewed journals examining semaglutide and tirzepatide use in routine clinical practice: Weight loss magnitude is generally lower than clinical trial averages Discontinuation rates are often higher due to side effects, cost, or access issues Adherence rates vary widely (50-80% at 12 months in various studies) Weight regain after discontinuation is common Cardiovascular and metabolic benefits are observed even with modest weight loss Clinical Data Interpretation: Clinical trial results represent average outcomes under ideal conditions

This is not a failure of willpower but rather reflects the medication's role in appetite regulation and the body's metabolic adaptation

We also explain refund rules so you know how to protect your purchase

While the theoretical long-term benefits to health outcomes are welcomed, the short-term cost impact to health insurers must be considered

TrimRx emphasizes personalized care, and this extends to ensuring you have accurate information for all medications in your plan